A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
2018 ◽
Vol 59
(5)
◽
pp. 1704
◽
2003 ◽
Vol 40
(3)
◽
pp. 149-154
◽
2010 ◽
Vol 55
(10)
◽
pp. A16.E147
◽